Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Market Cap	1.85B
Revenue (ttm)	776.26M
Net Income (ttm)	119.61M
Shares Out	570.21M
EPS (ttm)	0.21
PE Ratio	15.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,742,940
Average Volume	9,156,128
Open	2.840
Previous Close	2.840
Day's Range	2.690 - 2.860
52-Week Range	1.690 - 3.680
Beta	0.03
RSI	60.77
Earnings Date	Nov 10, 2025

About EGX:MCRO

Macro Group Pharmaceuticals (Macro Capital) S.A.E operates as a cosmeceuticals manufacturing company in Egypt and internationally. It engages in the production of pharmaceutical and cosmetic products, such as skin care, hair care, oral care, female intimate care, anti-scar, antiseptics, and topical muscle relaxants, as well as flavors, colors, and scents. The company also manufactures solid and liquid soap, herbal medicines, products and extracts, nutritional supplements, baby food, and special food products. It also offers its products online....

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2002
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MCRO

Financial Performance

In 2024, EGX:MCRO's revenue was 519.97 million, a decrease of -1.15% compared to the previous year's 526.01 million. Losses were -38.10 million, -86.03% less than in 2023.